Nanoviricides, Inc. SEC filings NNVC
Nanoviricides, Inc. has 556 filings in SEC EDGAR's recent list, going back to Nov 14, 2006. Its latest annual report, Form 10-K, was filed on Sep 28, 2026 for the period ended Jun 30, 2026. The latest quarterly report (Form 10-Q) was filed on May 15, 2026, covering the quarter ended Mar 31, 2026. The most recent current report (Form 8-K) was filed on Sep 29, 2026 (officer or director change). The company's fiscal year ends on June 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Oct 21, 2026 | — |
| 424B3 | Prospectus | Sep 3, 2026 | — |
| S-3 | Shelf registration | Aug 21, 2026 | — |
| 424B5 | Prospectus supplement | Jul 27, 2026 | — |
| 424B5 | Prospectus supplement | Jul 27, 2026 | — |
| 424B5 | Prospectus supplement | Jul 17, 2026 | — |
| 424B3 | Prospectus | Jul 1, 2026 | — |
| S-3 | Shelf registration | Jun 15, 2026 | — |
| S-3 | Shelf registration | Jun 5, 2026 | — |
| 424B5 | Prospectus supplement | May 18, 2026 | — |
| 424B3 | Prospectus | Dec 30, 2025 | — |
| S-3 | Shelf registration | Dec 15, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Nov 12, 2025 | — |
| 424B5 | Prospectus supplement | Aug 9, 2024 | — |
| 424B5 | Prospectus supplement | Apr 5, 2024 | — |
| 424B5 | Prospectus supplement | Aug 7, 2023 | — |
| S-3/A | Form s-3/a | May 8, 2023 | — |
| S-3 | Shelf registration | May 5, 2023 | — |
| 424B5 | Prospectus supplement | Dec 3, 2020 | — |
| 424B5 | Prospectus supplement | Jul 31, 2020 | — |
| 424B5 | Prospectus supplement | Jul 9, 2020 | — |
| 424B5 | Prospectus supplement | Jul 9, 2020 | — |
| 424B5 | Prospectus supplement | May 22, 2020 | — |
| S-3 | Shelf registration | Mar 24, 2020 | — |
| 424B1 | Filing | Jan 24, 2020 | — |
| S-1/A | Amended registration statement | Jan 8, 2020 | — |
| S-1/A | Amended registration statement | Jan 7, 2020 | — |
| S-1/A | Amended registration statement | Dec 23, 2019 | — |
| FWP | Free writing prospectus | Dec 17, 2019 | — |
| S-1/A | Amended registration statement | Dec 17, 2019 | — |
| S-1 | Registration statement | Nov 29, 2019 | — |
| S-1 | Registration statement | Sep 27, 2019 | — |
| 424B5 | Prospectus supplement | Mar 1, 2019 | — |
| 424B5 | Prospectus supplement | Nov 22, 2017 | — |
| S-3/A | Filing | Apr 18, 2017 | — |
| S-3 | Shelf registration | Mar 1, 2017 | — |
| POS AM | Filing | Apr 7, 2016 | — |
| 424B3 | Prospectus | Mar 6, 2015 | — |
| 424B3 | Prospectus | Dec 10, 2014 | — |
| S-3/A | Amendment to form s-3 | Nov 7, 2014 | — |
| S-3 | Shelf registration | Oct 31, 2014 | — |
| S-3 | Shelf registration | Jul 17, 2014 | — |
| 424B5 | Prospectus supplement | Jan 23, 2014 | — |
| S-3MEF | Registration statement | Jan 21, 2014 | — |
| 424B5 | Prospectus supplement | Sep 12, 2013 | — |
| 424B5 | Prospectus supplement | Dec 27, 2012 | — |
| S-3/A | Amendment to s-3 | Dec 3, 2012 | — |
| S-3 | Shelf registration | Oct 26, 2012 | — |
| 424B5 | Prospectus supplement | Jun 28, 2012 | — |
| 424B3 | Prospectus | Feb 8, 2012 | — |
| 424B5 | Prospectus supplement | Nov 1, 2011 | — |
| 424B3 | Prospectus | Jul 26, 2011 | — |
| 424B5 | Prospectus supplement | Apr 19, 2011 | — |
| 424B3 | Prospectus | Dec 20, 2010 | — |
| S-8 | Employee stock plan registration | Dec 10, 2010 | — |
| 424B5 | Prospectus supplement | Sep 21, 2010 | — |
| 424B5 | Prospectus supplement | May 12, 2010 | — |
| S-3/A | Nanoviricides inc s-3 a 3-15-2010 | Mar 15, 2010 | — |
| S-3 | Shelf registration | Mar 4, 2010 | — |
| S-1/A | Amended registration statement | Apr 8, 2008 | — |
| S-1/A | Amended registration statement | Mar 24, 2008 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- NNVC (NYSE)
- Fiscal year ends
- June 30
- Incorporated in
- DE
- Headquarters
- Shelton, CT
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1379006
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.